TherageniX to receive powdered gene therapy grant by John Pinching | Sep 5, 2023 | News | 0 The funding will boost the University of Nottingham spinout’s development of bone regeneration treatment Read More
Positive results for Evgen’s rhabdomyosarcoma therapy by John Pinching | Jun 27, 2023 | News | 0 Update on radiosensitising impact of SFX-01 when treating common soft tissue sarcoma condition Read More
Catalent completes cell therapy manufacturing facilities in Belgium by John Pinching | Dec 9, 2022 | News | 0 Facility represents one of the largest commercial-scale operations in the world Read More
Pfizer announces positive dermatitis therapy phase III results by Anna Smith | May 16, 2019 | News | 0 The company’s Janus kinase 1 has met all co-primary and secondary endpoints in a pivotal Phase III study. Read More